Fig. 1From: Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patientsThe serum levels of lnc34a in HCC patients with or without bone metastasis. Expression levels of lnc34a in serum from HCC patients with bone metastasis were significantly higher than those without bone metastasisBack to article page